We´re doomed we´re saved - Die Biorevolution
We’re doomed we’re saved mit Andreas Horchler und Louise von Stechow – Vater und Tochter, er Journalist, sie Biologin, sprechen über die Technologien der Biorevolution. Können Gentechnik, Synthetische Biologie und Künstliche Intelligenz die Menschheit vor Krankheit, Klimawandel und Überbevölkerung retten, oder sind diese Technologien der erste Schritt ihres Untergangs? Mehr unter https://science-tales.com/ Inhalt und Bearbeitung: Louise von Stechow und Andreas Horchler Bild: Kelly Sikkema via Unsplash
- Website
- https://science-tales.com/
- Description
- We’re doomed we’re saved mit Andreas Horchler und Louise von Stechow – Vater und Tochter, er Journalist, sie Biologin, sprechen über die Technologien der Biorevolution. Können Gentechnik, Synthetische Biologie und Künstliche Intelligenz die Menschheit vor Krankheit, Klimawandel und Überbevölkerung retten, oder sind diese Technologien der erste Schritt ihres Untergangs? Mehr unter https://science-tales.com/ Inhalt und Bearbeitung: Louise von Stechow und Andreas Horchler Bild: Kelly Sikkema via Unsplash
- Language
- 🇩🇪 German
- last modified
- 2024-11-23 07:24
- last episode published
- 2024-11-01 06:00
- publication frequency
- 30.37 days
- Contributors
- Louise von Stechow
- Author
- Louise von Stechow
- Owner
- Explicit
- false
- Number of Episodes
- 28
- Rss-Feeds
- Detail page
- Categories
- Life Sciences Natural Sciences Science & Medicine
Recommendations
Episodes
| Date | Title & Description | Contributors |
|---|---|---|
| 2024-11-01 | Science can be complex and difficult to grasp, yet public understanding is crucial for navigating issues like disease risk, climate change, and pandemics. Clear, engaging science communication can help prevent misinformation and conspiracy theories, of... |
|
| 2024-10-01 | In the expensive and failure-prone process of drug development, artificial intelligence (AI) can serve both as an efficiency tool and as a creativity tool. Increased efficiency means shorter timelines, reduced investment, and earlier insights into succ... |
|
| 2024-09-02 | How will the medicine of the future look? Healthcare and medicine are on the verge of transformative change, driven by new technologies such as artificial intelligence, telemedicine, and wearable devices. Alongside the technologization and virtualizati... |
|
| 2024-08-02 | Some 36 months after the release of ChatGPT, the verdict is still out on the role that large language models (LLMs) will play in biotech, pharma, and medicine. On paper, the range of tasks that LLMs can perform in biomedical research and healthcare is ... |
|
| 2024-07-02 | Rare or orphan diseases affect only a small percentage of the population and often lack effective treatments. While rare individually, in total, more than 350 million people worldwide live with rare diseases. Many of these are very hard to diagnose, le... |
|
| 2024-06-03 | When we think about revolutions, we think of systemic changes in politics, economics, and lifestyles. Revolutions transform how we live, work, interact, and communicate. In the past, political uprisings and new technologies, from the steam engine to th... |
|
| 2024-05-03 | Polygenic risk scores (PRS), put simply, look at gene variants across the human genome in order to determine an individual's risk of getting a disease, from different types of cancer to type II diabetes. PRS could complement current risk prediction mod... |
|
| 2024-04-03 | Aging is a dynamic process characterized by the accumulation of cell damage, tissue, and organ degeneration, and diminished function. This process of decline appears to be an inevitable aspect of human existence. In recent years, however, advancements ... |
|
| 2024-03-04 | Women make up about half of humanity. Yet, the medical community and the pharmaceutical and biotech industries have long adopted an androcentric view of disease biology and healthcare needs, perceiving women as a specialized or atypical demographic—out... |
|
| 2024-02-01 | RNA, one of the oldest and most versatile biomolecules, has recently entered the therapeutic arena. While for many observers the success of mRNA vaccines seemed to come out of the blue, its build on the fundament of research that has large gone ignored... |
|